This disaster is on the leadership team. They wanted to launch Wegovy as quickly as possible only to runout of supply 3 months later. Then we had to sell Saxenda again for another year while supply was built back up. Only supply ran out again. We launched a drug in June of 2021 and didn’t have consistent supply until March 2025. They also completely underestimated the compounded Semaglutide market even though reps kept bringing it up. Lastly, no innovation as we watched LillyDirect take over the cash market. But, blame the reps for not selling enough and cut them while home office is bloated and laughs during conference calls when we had no supply.
hey ya woke punk pipe it down. I’m group E so my Offer is in the bag. I have protection as my mgr is bringing me over from a previous role. You better be careful got it.
Who is this guy to take the call? He hasnt done anything great in his position as Chairman at BP. He messed up at BP and now doing the same here. Total asshole.